We invest in early-stage, niche HealthTech businesses and help them grow.
We bring a deep understanding of what it takes to build and operate successful HealthTech businesses. Leveraging experience from our first fund, we provide initial capital and growth expertise to help HealthTech entrepreneurs build defensible leaders in profitable niches.
Across our first fund, we reviewed ~3,000 companies over three years and completed 10+ investments.
We unite healthcare, entrepreneurial, and investment expertise - uniquely equipped to deliver on our strategy.
We back HealthTech businesses built for resilience, credibility, and sustainable profitability from the outset.
Platform
We provide software stack and hands-on support across market access, hiring, certifications, grants, and more.
We partner with early-stage HealthTech companies based on a clear set of investment criteria.
Revenue Ready
Already generating initial revenues, or advancing toward required certifications (if applicable) and market access in the short term.
Profitability First
Ability to reach break-even within 2-3 years after our investment and grow organically without reliance on additional funding rounds.
Niche Markets
Potential to become a #1 or #2 player in a defensible niche and generate a minimum of high-million-euro revenues within a medium-term horizon.
Deep Domain Expertise
Strong clinical, medical, or technical expertise, supported by a deep understanding of the target segment or care pathway.
Central & Eastern Europe
Operating in Central & Eastern Europe (including the DACH region), with a strategy to remain operationally anchored in the region.
Preventive care. Diagnostics.
Remote Care. Digital Therapeutics.
Showcasing our thriving portfolio companies and their inspiring success stories of growth, innovation, and market leadership
Meet the team - a unique convergence of health, entrepreneurial, and capital markets experience.
General Partner
Serial entrepreneur since 2005, co-founder of six companies. Active investor in HealthTech and beyond since 2023.
Senior Partner
Award-winning surgeon, professor, healthcare futurist, and entrepreneur. Nobel Prize nominee. 350+ keynotes worldwide.
Advisory Board
Partner at McKinsey & Company. Director at McKinsey Health Institute. Deep expertise in digital health, life sciences, and healthcare.
Advisory Board
Investor, Fund of Funds executive, and family enterprise advisor. Specialist in ownership, governance, and succession.
Senior Advisor
GI surgeon, digital health pioneer, and humanitarian. Builder of virtual care platforms across Central Europe. Healthspan advocate.
Senior Advisor
Former CEO & Board Director at Impact Hub Global. Management consultant specialized in organizational change and growth.
Advisory Board
Entrepreneur, investor, and former strategy consultant. Co-founder of Impact Hub Czechia and Tilia Impact Ventures.
Investment Committee
Serial entrepreneur with three exits. Partner at Purple Ventures, investing in early-stage technology businesses.
Investment Committee
Co-founder of Kickstart Innovation (500+ program alumni, €3B+ raised). Co-founder of a 60+ person software house.
Senior Advisor
Healthcare venture builder. Former Senior Executive at Merck, Roche, and Novartis. Deep expertise in organizational development.
Associate
LSE alumnus with a background in corporate finance. Investment professional with a passion for innovation and impact.
Seasoned venture capitalist with expertise in identifying high-potential startups and providing strategic guidance.
Meticulous investment analyst specialising in market research, financial modeling, and due diligence.
Tech-savvy expert with a deep understanding of emerging trends and disruptive technologies.
Efficient operations manager driving process optimisation and scalability for portfolio companies.
Strategic consultant offering valuable insights to navigate complex market dynamics.
Marketing maven amplifying brand presence and attracting investors for portfolio companies.
Financial expert managing investor relations and securing funding for portfolio companies.
Skilled in expanding networks and fostering partnerships for growth opportunities.
Seasoned venture capitalist with expertise in identifying high-potential startups and providing strategic guidance.
Meticulous investment analyst specialising in market research, financial modeling, and due diligence.
Tech-savvy expert with a deep understanding of emerging trends and disruptive technologies.
Efficient operations manager driving process optimisation and scalability for portfolio companies.
Strategic consultant offering valuable insights to navigate complex market dynamics.
Marketing maven amplifying brand presence and attracting investors for portfolio companies.
Financial expert managing investor relations and securing funding for portfolio companies.
Skilled in expanding networks and fostering partnerships for growth opportunities.
Seasoned venture capitalist with expertise in identifying high-potential startups and providing strategic guidance.
Meticulous investment analyst specialising in market research, financial modeling, and due diligence.
Tech-savvy expert with a deep understanding of emerging trends and disruptive technologies.
Strategic consultant offering valuable insights to navigate complex market dynamics.
Marketing maven amplifying brand presence and attracting investors for portfolio companies.
Financial expert managing investor relations and securing funding for portfolio companies.
Skilled in expanding networks and fostering partnerships for growth opportunities.
Not chasing unicorns.
AI and GenAI tools are fundamentally changing what it takes to build a company. By dramatically reducing the cost of experimentation, development, and growth, they are opening doors to opportunities that once demanded substantial upfront capital.
A new generation of entrepreneurs is emerging - building profitable, technology-enabled businesses in areas that were previously economically unreachable.
During our first fund, we met hundreds of such entrepreneurs pursuing opportunities in healthcare - yet struggling to secure funding. The problem wasn't the entrepreneurs. It was that healthcare's realities rarely deliver the exponential growth venture capital demands.
That insight became the cornerstone of our second fund - PT Capital. We designed a strategy that allows us to back bold teams in niche, highly attractive healthcare markets - companies other investors can't support, not for lack of quality, but because their unicorn-chasing models don't allow it.
%20copy_v3.jpeg)
.png)